Fact CheckerSign in

NCT06246448Recruiting

Robotic-assisted Contra Open Resection for Suspected or Confirmed Gallbladder Cancer (ROBOCOP)

Robotic-assisted Contra Open Resection for Suspected or Confirmed Gallbladder Cancer - An International, Multi-centre, Single Blinded, Randomized Controlled Superiority Trial

Source: ClinicalTrials.gov · Last updated 5 Sept 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

The Robocop trial is an international multi-centre, single blinded, randomized controlled superiority trial conducted in centres experienced in robotic-assisted liver surgery. Eligible patients for radical cholecystectomy will be randomized in a 1:1 ratio to undergo robotic-assisted or open resection within an enhanced recovery setting. The primary endpoint is time to functional recovery. Secondary endpoints include length of hospital stay, resection margin, number of retrieved lymph nodes, postoperative complications, quality of life, abdominal wall complaints and direct and indirect costs.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
94 (estimated)
First submitted
22 Jan 2024
Start date
23 Jan 2024
Primary completion date
Oct 2026
Lead sponsor
Karolinska University Hospital
NCT number
NCT06246448

What you commit to

  • Study type: Interventional
  • Planned participants: 94
  • From 23 Jan 2024 to the primary completion date, Oct 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Previous extensive surgery in the upper abdomen (for example open liver surgery)
  • Intraoperative findings of the need to perform resection of extrahepatic bile ducts (patient is then excluded after randomization).

Other

  • Pregnancy
  • Intraoperative findings of dissemination (patient is then excluded after randomization)
  • Intraoperative findings leading to a simple cholecystectomy only (patient is then excluded after randomization)

Who the study is looking for

  • Patient with radiologically suspected or confirmed (≥T1b) incidental gallbladder cancer after cholecystectomy with an indication of radical cholecystectomy, without the need for resection of extrahepatic bile ducts, as decided at a multidisciplinary team conference.
  • Patient sufficiently fit to undergo radical cholecystectomy according to surgeon and anaesthesiologist.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Region Stockholm
Coordinator of this site? Confirm its status
StockholmSwedenRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.